Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort Study.

Matthew A RutherfordJennifer ScottMaira KarabayasMarilina Antonelou Seerapani GopaluniDavid GrayJoe BarrettSilke R BrixNeeraj Dhaun Stephen P McAdooRona M SmithColin C GeddesDavid JayneRaashid LuqmaniAlan D SalamaMark A LittleNeil Basunull null

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2021)

In patients with systemic vasculitis, glucocorticoid use at presentation and comorbid respiratory disease were associated with severe outcomes in COVID-19. These data can inform clinical decision-making relating to the risk of severe COVID-19 in this vulnerable patient group.

Keyphrases

coronavirus disease
sars cov
early onset
decision making
drug induced
case report
respiratory syndrome coronavirus
adipose tissue
data analysis